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ABSTRACT
Immunosuppression by Aflatoxin B, in C57BU6 Mice and its
Relationship with Neuroendocrine Mechanisms
by
Yasuhiko Hatori, Master of Science
Utah State University, 1990
Major Professor: Dr. Raghubir P. Sharma
Department: Toxicology/A.D.V.S.
Aflatoxin B, (AFB,), a secondary metabolite of Aspergillus flavus and
Aspergillus

parasiticus,

is

known

for

its

potent

carcinogenicity

and

immunosuppressive effects. It is also known that AFB, toxicity appears in different
degrees in different animal species and strains.
The present study was performed to reveal the involvement of the
hypothalamus-pituitary-adrenal gland (HPA) axis in the immunosuppressive effects
of AFB, on C57BU6 mice. Splenic lymphocy1es were assayed to investigate their
phenotyping using flow cy1ometry, proliferative response against mitogen and
allogenic lymphocy1es, cy1oly1ic cell activity, and IL-2 production.

In addition,

antibody-mediated immunocompetence was checked using sheep red blood cell
(SRBC)-challenged animals by plaque-forming cell (PFC) assay and enzyme-linked
immunosorbent assay (ELISA).

Corticotropin releasing factor (CRF) in brain

hypothalamus and cerebral cortex, plasma adrenocorticotropic hormone (ACTH),
and corticosterone were determined by radioimmunoassay (RIA).

Hypothalamic

catecholamine and its metabolites were assayed by high-performance liquid

xiii
chromatography (HPLC). The adrenalectomized animals and their respective control
animals

were

used

to

evaluate

corticosterone

involvement

in

AFB,

immunosuppressive effects.
A relatively higher dose was applied in the present study, compared to the
previous studies that used different strains of mice.

Immunosuppressive effects

were observed in blastogenic response, IL-2 production, and primary antibody
production of splenic cells. The amount of circulating anti-SRBC antibody was also
affected. Decreases were observed in the helper-T cell and B cell percentage in
phenotyping splenic lymphocyte. No significant changes were observed in natural
killer cell activity, mixed lymphocyte response , brain biogenic amine concentrations,
concentration of CRF in the hypothalamus, and those of ACTH and corticosterone
in plasma. However, the expected effect of adrenalectomy to compensate for the
immunosuppression of AFB, was not observed.
The results indicate that the HPA axis does not appear to have a major role
in AFB,-induced immunotoxicity.
(117 pages)

CHAPTER I
INTRODUCTION
Mycotoxins are chemicals produced as secondary fungal metabolites that
may induce a variety of toxic responses in animals (including humans) . More than
100 mycotoxins have been structurally characterized.
Aflatoxin B, (AFB,) is one of these mycotoxins, a secondary metabolite of
Aspergillus flavus and A. parasiticus. Aflatoxin B, can induce lethal mold poisoning

in humans and animals when they are exposed severely; it is also known for its
hepatotoxicity and powerful hepatocarcinogenicity (Williams and Weisburger, 1986).
It is the most potent natural carcinogen known .
Aflatoxin B, also effects the immune system (Hoerr and D'Andrea, 1983;
Giambrone et al., 1985a, 1985b, 1985c; Reddy et al., 1987; Reddy and Sharma,
1989).

It has been reported that AFB, effects the central nervous system

(lkegwuonu, 1983; Ahmed and Singh , 1984; Coulombe and Sharma, 1985;
Jayasekara et al., 1989). Aflatoxin B, is metabolized to strong alkylating agents,
which may have effects on enzymes and brain amines.
The interrelationship of the immune system and the nervous system has
been well established (Besedovsky et al. , 1985). The immune system has been
known to be influenced by various types of stresses, of which there are several
degrees in human and experimental animals. Gellhorn and Loofbourrow (1963, p.
211) noted "burns and other forms of injury to the body, exposure to cold or to
lowered barometric pressure, injection of toxic substances, necrosis of body tissues,
and painful stimulation, all are causes of stress." During a stress response , "the
adrenal cortex becomes hypertrophic, wh ile the thymus and the lymph nodes show
a reduction in size." The stress of emotional excitement may also cause similar
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effects. Stress causes activation of the autonomic nervous system (particularly the
sympathetic division) . The secretion of adrenocorticotropic hormone (ACTH) can
be increased by stimulation of the hypothalamus. In an experiment using monkeys,
prolonged mild stimulation of the hypothalamus elicited a maximal secretion of
ACTH (Mason, 1959).

McCann and Haberland (1960) noted in their study that

discrete lesions in the hypothalamus greatly reduced or abolished effects of various
forms of stress.

The releasing mechanism of ACTH can be activated by the

cerebral cortex and reduced by the hippocampus stimulation (Lissak and Endroczi,
1960). As a result of lesions or transection of the stalk, ACTH secretion is reduced
to only a tracer level; later stresses and humoral factors are practically ineffective
(Gellhorn and Loofbourrow, 1963). Various types of stress cause excitation of the
hypothalamus, which may be blocked by specific hypothalamic lesions.
Exogenous corticosteroid depresses immune responsiveness.

Steroids

intervene at many points in the immune response; for example , they affect
lymphocyte recirculation and the generation of cytotoxic effector cells.

Their

remarkable anti-inflammatory potency depends on features such as inhibition of
neutrophil adherence to vascular endothelium in an inflammatory area and
suppression of monocyte/macrophage functions such as microbicidal activity and
response to lymphokines (Raitt, 1980).
There are many reports that attempt to establish a relationship between the
hypothalamus and immune responsiveness . Keller et al. (1980) used an anterior
hypothalamic lesion in guinea pigs to cause a delayed cutaneous response to
antigen and a suppressed in vitro correlate of cell-mediated immunity, lymphocyte
stimulation in whole blood.

Kate et al. (1986) mentioned a delayed-type

hypersensitivity (DTH) depression in mice with hypothalamic lesions induced by

3
monosodium glutamate.

In the case of T-2 toxin (Taylor, 1988), benzene, or

toluene (Hsieh, 1988), additional adverse effects via HPA axis on immunomodulation
effects were suggested .
Taylor et al. (1989) reported on the involvement of the hypothalamic-pituitaryadrenal (HPA) axis in T-2 toxin-induced immunosuppression.

T-2 toxin, another

potent mycotoxin produced by the Fusarium species, has been shown to alter
immunologic functions in several species, including mice (Taylor et al., 1985). The
effects of T-2 toxin on the cells directly involved in immune functions have been
documented (Taylor et al. , 1987). The effects of this mycotoxin include damage
to gastrointestinal tract mucosa and predisposing an animal to ensuing events of
inflammation.

In their report, Taylor et al. (1989) indicated that an oral exposure

of mice to T-2 toxin increased blood levels of corticosterone. This increase was
concomitant with an increase in hypothalamic norepinephrine and endotoxemia. T2 toxin probably produced these effects following ulcuation of the nonglanduler
portion of the stomach, leading to endotoxemia and resulting in a stress syndrome.
Since AFB, has been reported to increase hypothalamic norepinephrine in mice
(Jayasekara et al., 1989), it was considered important to investigate the effects of
repeated AFB, exposure on the HPA axis and related immunosuppression .
These works show that immune responses might be modulated by
endogenous hormone interactions via corticotropin-releasing factor (CRF), ACTH,
and adrenocortical hormone.
Although AFB, has been well studied for its effects on the immune system,
the endocrine role in AFB,-induced immunosuppression has not been investigated.
In the present study, the involvement of the HPA axis in the immunosuppressive
effects of AFB, was studied. Inbred C57BU6 mice were employed in these studies

4

since this strain has not been previously investigated for the immunosuppressive
effects of AFB,.

5
CHAPTER II
LITERATURE REVIEW
Mycotoxins

Mycotoxins belong to a group of chemicals that are produced as secondary
fungal

metabolites and have

conformations.

unique biological

properties

and structural

These induce a variety of toxic responses in animals (including

humans) when ingested feeds are contaminated by them.
mycotoxins have been characterized structurally.

More than 100

Most of these mycotoxins are

relatively nontoxic; however, some of them, such as aflatoxin B, and certain
trichothecenes, induce lethal mold poisoning in exposed human and animals.
Further classification of these

mycotoxin is as follows : polyketides (aflatoxins),

terpenes (trichothecenes), and proteins (ergot toxins) (Bu'lock, 1980; Fernando et
al., 1986).
Aflatoxins

Aflatoxins were discovered to be the causative agent of a disease in eastern
and southern England known as "turkey X disease". This disease caused death
in thousands of young turkeys, ducks, and pheasants. The symptoms were lethargy
and loss of appetite, and death resulted within a week. Extensive hepatic necrosis
and hemorrhage with frequent engorgement of the kidneys were observed. Further
examination showed parenchymal degeneration and bile duct proliferation in the liver
(Goldblatt, 1969).

A similar disease was reported in ducklings in Kenya and

Uganda, with pigs and calves also affected (AIIcroft, 1969). Any microbiological
or viral etiology was ruled out.

Finally, feed was found to be contaminated with

fungal hyphae. The cultured fungus produced toxin that was eventually designated
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"aflatoxin" from the contraction of Aspergillus flavus toxin.

"The problem of

aflatoxicosis might have essentially been a veterinary problem, if not for the interest
of the World Health Organization in providing peanut meal as a protein supplement
to undernourished children" (Busby and Wogan, 1984, p. 947).
The production of aflatoxins has been confirmed in only two strains
(Aspergillus flavus and A. parasiticus) . Toxin production occurs after cultivation on

a variety of substrates; however, contamination with these fungi does not
necessarily indicate the presence of aflatoxins.
aflatoxin production are:

The conditions necessary for

1) sufficient growth, 2) moisture content and chemical

composition of the substrate, 3) appropriate environmental conditions (temperature,
humidity). and 4) aeration.
Four major aflatoxins--AFB,, AFB 2 , AFG ,. and AFG 2 --were named for their
separation characteristics on thin layer chromatography (TLC) and fluorescent color
under UV light, where B is blue and G is green.

The subscripts relate to their

relative mobility on TLC. A total of 13 naturally-occurring derivatives have been
structurally identified, many of which belong to the AFB, series of derivatives
(Wogan, 1977). Knowledge of aflatoxins' carcinogenicity, toxicity, and biochemical
effects on various biological systems is rapidly increasing.
Aflatoxin B,
Chemistry
The Aflatoxin B, structure is characterized by the fusion of a cyclopentenone
ring to the lactone ring of the coumarin structure.
fluorescence under ultraviolet light.
Table 11-1.

AFB, shows a strong blue

The chemical structure of AFB, is shown in
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TABLE 11-1
PHYSICOCHEMICAL CHARACTERISTICS OF AFB,
Data

Characteristics
Molecular formula
Structure

Melting Point(°C)
[a]o
UV max
Fluorescence emission

268-269
-558°(c;0.1 in CHCI 3}
-480°(C;0.1 in DMF)
223 nm (£=25,600)
265 nm (£=13,400)
362 nm (£=21,800)
425 nm

AFB, is soluble in methanol , chloroform , and other organic solvents but is only
sparingly soluble in water ( 10-30 llgiml)
Modified from Busby and Wogan (1 984) .
£= molar absorptivity
Prevalence
Aflatoxin exposure in humans may be due to the consumption of
commodities that have been directly contaminated by A. flavus or A. parasiticus.
Secondary exposure may occur from the consumption of products derived from
animals

that

have

consumed

aflatoxin-contaminated

feeds.

Because the

requirements for aflatoxin production by toxigenic fungal species are relatively
nonspecific, aflatoxins can be produced on virtually any foodstuff.

Nearly all

agricultural commodities can be contaminated with aflatoxins if handled under
appropriate conditions during growth, harvest, or storage. Grains, peanuts, oilseeds,
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legumes, tree nuts, fruits, vegetables, spices, beverages, eggs, meats, and dairy
products have all been reported to be contaminated to some extent (Busby and
Wogan, 1984).
Epidemiology
Acute aflatoxicosis in humans has been reported in Taiwan and Uganda
(Shank, 1977; 1981). The syndrome is characterized by vomiting, abdominal pain,
pulmonary edema, and fatty infiltration and necrosis of the liver. In India, accidental
consumption of contaminated corn caused more than 100 fatalities in 1974. The
deaths were the result of gastrointestinal hemorrhage.

The syndrome was not

infectious and occurred only in the households where the contaminated corn was
consumed. Extensive bile duct proliferation was observed, which is often noted in
experimental acute aflatoxicosis in animals.
Aflatoxicosis is a suspected cause of Reye's syndrome (Ryan et al., 1979;
Nelson et al., 1980), a disease first reported in Northern Thailand and later in
several other countries.

It is characterized by cerebral edema and neuronal

degeneration in adolescent children .

The relationship, however, has not been

confirmed (Busby and Wogan, 1984).
Toxicology
The single oral LD 50 for AFB, in several animal species is given in Table 112 (Busby and Wogan, 1984). The general nature of aflatoxicosis is similar in all
affected species (Pier, 1981).

In chronic aflatoxicosis, the liver is usually pale to

yellow, and the gall bladder enlarged. Histopathological examination reveals fatty
changes in hepatocytes, periportal fibrosis, and extensive bile duct proliferation in
some species (Newberne, 1973).
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TABLE 11-2
TOXICITY OF AFB, IN VERTEBRATES
Species

Strain

Age and/or Weight

Sex

LD 5,
(mg/kg)

··------------------------------------------------------------------------------------------------------------Duck

Peking

1d

M&F

Chicken

Australian
Broiler

3w

M
250 g

Guinea pig
Hamster

0.34
15-18

M&F

1.4

30 d

M

10.2

Rat

Porton-Waster
Fisher

100-150 g
42 d (75 g)

M
M

7.2
4

Mouse

CFW Swiss

30 d (20 g)

M

10.2

Rabbit

Dutch Belted

3m

M&F

0.55

Cat

Mixed breed

adult

M&F

0.5-1.0

Dog

Mixed breed

adult

M&F

0.62

Pig

Poland-China

weanling (6-7 kg)

M

2.0

Sheep

Cross breed

M

2.02

Monkey
cynomolgus
macaque

2 y
2 y
38-44 m

Modified from Busby and Wogan (1984).

M
F

2.2
7.8
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Metabolism
Aflatoxin B, is primarily metabolized by the cytochrome P-450 system, located
mainly in the endoplasmic reticulum of liver cells.

The enzymatic conversion is an

essential step in the formation of the highly active intermediate, AFB,-2,3-epoxide,
which is thought to be responsible for AFB,'s carcinogenicity and other toxicities
(Miller and Miller, 1974; Garner and Wright, 1975).
The metabolic pathways for Aflatoxin B, are depicted in Fig.ll-1 . One of the
most important metabolites of Aflatoxin B, is AFM,, which is formed by ring
hydroxylation of AFB, at the 4 position (AIIcroft and Carnaghan, 1963).
susceptibility to Aflatoxin B, toxicity can be correlated with

Species

differences in

metabolism and disposition (Portman et al., 1970 ; Patterson, 1973; Salhab and
Edwards, 1977; Hsieh et al. , 1977; Monroe and Eaton, 1987; 1988). Aflatoxin B,
is metabolically converted to a variety of stable metabolites, including aflatoxicol
(AFL) , aflatoxin M, (AFM ,), and aflatoxin 0 , (AFO,) in vivo or in vitro.
Carcinogenicity
The mycotoxin, AFB, has been shown to be a potent carcinogen in many
species of animals, including rodents (rats, mice, and hamsters). nonhuman
primates (rhesus monkeys). birds (ducklings), and fish (rainbow trout) (Wogan, 1973;
Dickens and Jones, 1965; Dickens, 1967; Vesselinovitch et al., 1972; Adamson et
al., 1973). Generally, the liver is the primary target organ. The use of aflatoxincontaminated meal or a crude aflatoxin mixture containing variable amounts of AFB,
and AFG, in many early studies has been reviewed in detail (Wogan, 1973).
Aflatoxin

B,

causes

primarily

hepatocellular

carcinoma

and

cholangiocarcinoma in the liver. Renal adenocarcinomas have also been reported
in several strains of rats (Wogan, 1976). Other tissues affected include the trachea
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Fig . 11-1 Metabolic transformation of AFB,
[Reproduced from Busby and Wogan {1984) with permission]
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and the skin (Wogan et al. , 1971; Lindenfelser et al., 1974).
Species and strain susceptibility
Many reports have been published to describe species differences in the
toxicity of AFB,.

Acute toxicity of AFB, is summarized in Table 11-2.

Mice are

relatively resistant to both the acute and carcinogenic effects of AFB,.

A dietary

level of 1.0 ppm consistently induces a high incidence of liver carcinoma in several
rat strains (Wogan and Newberne , 1967; Wogan et al., 1974; Epstein et al. , 1969),
whereas inbred mice show no evidence of carcinogenic response at this level
(Wogan, 1973).

It had been concluded that AFB, is metabolized faster in the

mouse liver than in the rat liver enzyme systems (Portman et al., 1970). Later, the
oxidation potential of AFB, was shown to be quite similar in both species (Roebuck
and Wogan, 1977, Hsieh et al. , 1977).
Wong and Hsieh (1980) reported the metabolism and toxicokinetics of AFB,
in three laboratory animal species.

They concluded that the mouse is relatively

resistant to AFB, toxicity compared with the rat and the monkey and that the
distribution , metabolism, and elimination of AFB, from the body is responsible for
those differences. Species that are more sensitive to AFB, toxicity demonstrate a
higher volume of distribution and a longer plasma biological half-life for AFB,.
Even in the same species, there is wide variation in the toxic and
carcinogenic effects of AFB, in different strains.

Fifteen percent of White Swiss

mice fed a peanut-meal diet containing 1 ppm AFB, for 16 months developed liver
tumors (Newberne and Butler, 1969), whereas the same concentration of the
mycotoxin failed to induce tumors in Swiss, C3HfB/Hen , and C57BUSNB strains
even after 70 weeks (Wogan, 1969).
Monroe and Eaton (1987, 1988) compared hepatic glutathione S-transferase
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(GST) activity toward the AFB,-epoxide between rat liver cytosol and that of mice.
Mouse liver cytosol had 52 times greater GST activity. It was concluded that GST
is the principal determinant of species differences in susceptibility to AFB,-induced
hepatocarci nogenicity.
lmmunotoxicology

It has become increasingly apparent that the immune system acts as a
target organ for a number of different xenobiotics (Dean and Vas, 1986). There
appears to be a growing volume of literature describing the immunotoxicology of
various compounds. The immune system has many sensitive parameters which are
easily determined (Dean et al. , 1982, 1986; Thomas et al. , 1985).
Because the immune system is composed of continuous proliferating cells
and a tightly-regulated, highly-organized network, it is thought to be sensitive to
xenobiotics.

An imbalance or blocking of the one or both features may lead to

pathogenic infections, allergic or autoimmune disorders and cancer.
Chemicals can cause several reactions in the immune system.

Many

chemicals or their metabolites are recognized as antigens, either alone or
conjugated with host protein.
competence.

Other chemicals enhance or support immune

Enhanced immune potential may lead to increased host resistance

or to autoimmunity; decreased immune function may lead to a lack of appropriate
response.

It is also possible for these interactions to occur at the same time in

various combinations.
To detect slight modification in immune responsiveness, sensitive assay
systems, requiring better standardization , must be employed (Dean et al. , 1986;
Thomas et al., 1985a; Sharma and Zeeman, 1980). Table 11-3 summarizes assays
used to measure host immunity and the end points measured.
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TABLE 11-3
IMMUNE FUNCTION ASSAY•
Parameter

Procedure employed

Comments or
cells involved

Pathotoxicology

Hematology profile
Red blood cell count
White blood cell count

Indication of overall effects
on the immune system

Weights
body, spleen, thymus, liver,
kidney, adrenal gland
Lymphocyte
phenotyping

Flow cytometry

The effects on T-cell
(cytotoxic, suppressor}

Lymphocyte
proliferation

Blastogenesis
Con A
PHA
LPS
PWM

CMI
T-cells (helper, suppressor}
T-cells (helper)
B-cells
B- and T-cells

One-way mixed leukocyte culture CMI
Cytotoxicity

" Cr release assay

Humoral immunity Immunoglobulin level
lgM (ELISA)

Lymphokine

CMI
NK cell
T-dependent
(SRBC)

Plaque assay

T-dependent
(SRBC)

IL-2

CMI

•· Abbreviations used in this table, ConA, PHA, LPS, PWM , lgM, ELISA,
IL-2, CMI, NK cell, and SRBC, are shown in the List of Acronyms and
Abbreviation Used in Text (pages vi-viii) .
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lmmunotoxic assessment, in addition

to

current

safety

assessment

procedures, may be requ ired for many chemicals and drugs in future studies (Exon
et al. , 1986).
The effects of Aflatoxin B,
exposure on the immune system
Aflatoxin B, has been shown to have immunosuppressive effects on different
species of animals and appears to decrease resistance to infectious disease. In
pigs, AFB, exposure decreased the lymphocyte response to mitogens, the inhibition
of macrophage migration , the delayed hypersensitivity skin response , and the
antibody titer to sheep erythrocytes (Hoerr and D'Andrea, 1983).

More severe

clinical symptoms were reported in AFB, -exposed pigs than in control pigs after
inoculation with Salmonella cholerasuis (Miller et al. , 1978).
Aflatoxin 8,-exposed chickens and turkeys showed deficiency in cell-mediated
immunity, measured by a delayed hypersensitivity skin test to Mycobacterium. No
effects on humoral immunity or acquired immunity to Newcastle disease or fowl
cholera vaccination were noted (Giambrone et al. , 1985a, 1985b, 1985c).
Michael et al. (1973) reported strongly inhibited phagocytic activity and
general reticuloendothelial system (RES) impairment in chickens suffering from
acute aflatoxicosis.

Depressed cell-mediated immune activity was reported in

guinea pigs by Pier (1981).
Reddy et al. (1987) reported immunosuppression in male CD-1 mice exposed
to AFB, every other day over a period of two weeks. They found the reduction of
responses to several mitogens and decreased DNA synthesis in mixed lymphocyte
cultures.

Reduction in antibody production to T-dependent antigen (sheep red

blood cell) was observed, but antibody production to T-independent antigen (LPS)
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was not affected. A reduction in delayed-type hypersensitivity to keyhole limpet
hemocyanin was also observed.

The association of protein synthesis to

immunosuppressive effects of AFB, was suggested in this report.
Similar effects of AFB, treatment (every other day for four weeks) on BALB/c
mice were observed by Reddy and Sharma (1989). Responses to mitogens were
suppressed in a dose-related manner. Peripheral leucocyte counts and natural killer
cell function were decreased. Decreased DNA, RNA, and protein synthesis were
observed in the case of in vitro AFB, exposures. On the other hand, after in vivo
exposure to AFB,, DNA synthesis was depressed, but RNA and protein synthesis
was not affected or even stimulated by a low dose; the stimulation was also
observed in DNA synthesis with the non-specific mitogen (PWM) and the T-cell
specific mitogen (PHA).

From in vitro experiments, the authors concluded that

AFB, exposure: 1) affects T cells more than B cells, and 2) helper T cells were
more sensitive to AFB, than suppressor T cells, particularly at low AFB,
concentrations.
Neurochemical approaches to
toxicology

Neurotoxic agents can affect the nervous system in diverse ways (Bondy,
1985; Norton, 1986; Cooper et al., 1986; Mitchell, 1982). Some act directly on the
nervous system, whereas others disturb non-neuronal processes. Some neurotoxins
can change the blood-brain barrier by changing cellular permeability.

Some can

alter neurotransmitter synthesis, storage, release, uptake, or secretion (Bondy, 1985;
Mailman and Dehaven, 1984).
Most

studies

have

focused

on

monoaminergic

neurotransmitters,

catecholamines (dopamine and norepinephrine) and indoleamine (serotonin or 5-
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hydroxytryptamine [5-HT]). A number of neurological and psychiatric syndromes are
caused by an excess or deficiency of these specific neurotransmitters (Willis and
Smith, 1985; Poirier and Bedard, 1984). A number of chemicals have been shown
to cause a variety of effects on neurochemical transmitters (O'Donoghue, 1985;
Sharma et al., 1986; Coulombe and Sharma, 1985; 1986).
Because neurotransmitter concentrations are different in discreet brain parts,
it is difficult to detect their changes when measured in whole-brain homogenates.
A dissected brain region should be assayed to get useful information (Commissiong,
1985; Bondy, 1986). The hypothalamus, thought to be the most important region
among these regions, is connected to entire body by way of various hormone
secretions,

and

more

exposed

to

circulating

chemicals

because

of

the

incompleteness of its blood-brain barrier (Bondy, 1985).
Neurotransmitters

Catecholamines
The catecholamines dopamine (DA), norepinephrine (NE), and epinephrine
(EPI) are neurotransmitters that play important roles in the brain and peripheral
sympathetic system.

Norepinephrine has been proposed to be a central

neurotransmitter, since it is not found to be uniformly distributed in the brain.
Dopamine, a precursor for these catecholamines, is synthesized by dopadecarboxylase from L-dopa. Dopamine-p hydroxylase works on DA to synthesize
NE, whereas phenylethanolamine-N-methyltransferase works on NE to synthesize
EPI. Dopa-decarboxylase is the rate limiting enzyme in this pathway. The relative
concentration of EPI in the brain is extremely low compared to the peripheral
tissues.
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The precursors for brain amines are supplied from the blood stream and
used for synthesis of neurotransmitters in the nerve cell body.

Synthesized

transmitters are transported down to end of the axon and secreted.
According to Krassner (1983) , there are three
neurotransmitter systems in the brain :

main catecholamine

1) the extra-pyramidal system, which

includes coordination and integration of fine muscular movement; 2) the mesolimbic
system, which relates memory and emotion; and 3) the hypothalamic pituitary axis,
which controls endocrine-related activities. The NE-producing neurons in the brain
control the visceral functions (hunger, thirst, temperature regulation , blood-pressure
regulation , reproduction, and behavior) , whereas the EPI (found in small amounts
in the brain) controls emotion, mood, and behavior.
lndolamine
lndolamine (serotonin or 5-HT) is found in high concentrations in the
hypothalamus, midbrain, and brain-stem. The rate-limiting enzyme of synthesis is
tryptophan hydroxylase, an enzyme that converts tryptophan to 5-hydroxytryptophan,
which, in turn , is converted to 5-HT by 5-hydroxytryptophan-decarboxylase . Major
physiological functions of 5-HT are regulation of the anterior pituitary, sleep,
awareness of pain, temperature control, blood-pressure regulation, respiration
control, and heart-rate control.

It is also related to memory (Brownstein, 1981 ).

Steplewski and Vogel (1985) reported that increased 5-HT in the brain was
associated with decreased tumor formation and increased tumor rejection .
The effects of Aflatoxin 81 exposure
on neurotransmitters
AFB, is reported to alter neuronal ATPase in the peripheral and central
nervous system (lkegwuonu, 1983).

Weekly and Llewellyn (1984) observed the
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reduction of whole brain tryptophan hydroxylase in rats.

A significant change in

whole-brain serotonin levels in chickens after a single oral dose of AFB, was
reported by Ahmed and Singh (1984).
Central and systemic tryptophan metabolism was altered in male SpragueDawley rats following AFB, treatment (1 mg/kg, given i.p. over a period of 10 days).
The activity of tryptophan hydroxylase was reduced by this treatment (Weekly and
Llewellyn, 1984).

Recently, Coulombe and Sharma (1985) reported that AFB,

decreased striatal dopamine (DA) and its metabolites, dihydroxyphenylacetic acid
(DOPAC) and homovanillic acid (HVA), in rats exposed to AFB, twice weekly for
there weeks.
Major effects of AFB, exposure in male CD-1 mice were found with
increased concentration of norepinephrine (NE) in most brain areas investigated.
The increase of DA concentration in the hypothalamus and the corpus striatum,
accompanied by increase of dopa-decarboxylase activity, and the increase of 5-HT
accompanied by increase of tryptophan hydroxylase activity was also reported
(Jayasekara et al., 1989). These findings were apparently not in agreement with
the rat experiments.
Relationships of the immune,
endocrine, and neurotransmitter
systems

It was formerly thought that the regulation of the immune system was
completely autonomous (Locke and Colligan, 1986); however, much evidence has
been presented to indicate that the immune and nervous systems act in concert.
It is now believed that both systems share some reciprocal regulatory mechanisms
in conjunction with the endocrine system (Besedovsky et al., 1983b).
There is sufficient supporting evidence to suggest such a interrelationship.
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First, there is adrenergic innervation of lymphoid organs such as the spleen,
thymus, lymph nodes, bone marrow, and gut-associated lymphoid tissue (Felten et
al., 1985; Reilly et al., 1976, 1979).

Second, there are adrenergic- and

neurohormone-receptor sites located on some lymphocy1es (Hadden et al., 1970;
Singh et al. , 1979).

Third, alterations of brain biogenic amine levels may have

either an enhancing or a suppressive effect upon lymphocy1e functions (Besedovsky
et al. , 1985; Del Rey et al., 1981; Sanders and Munson, 1985).

Fourth ,

immunocy1es produce a number of chemical substances that can alter biochemical
pathways in the central nervous system (CNS) (Besedovsky et al., 1983a, 1985;
Blalock, 1984).
Claman (1972) concluded that adrenal glucocorticoids interacted with
lymphoid cells.

Tala! and Ahmed (1987) stated that adrenal steroid hormones,

grow1h , adrenocorticotropin (ACTH), and sex hormones regulate the immune system
at least to some extent.

Besedovsky et al. (1986) suggested that an

immunoregulatory feedback mechanism exists between the T-cell lymphokine
interleukin-1, and the endocrine hormones (ACTH and glucocorticosteroids).
McEven (1987) reviewed the interactions between the endocrine and the
nervous systems, and concluded that glucocorticosteroids: 1) raise 5-HT, NE, and
possibly

DA

levels

in

the

adrenal

medulla

and

brainstem;

2)

maintain

phenylethanolamine N-methyl transferase (PNMT) [NE to EPI] activity in the adrenal
medulla and brainstem and DA-~-hydroxylase [Dopamine to NE] activity in the
hypothalamus; 3) increase acutely tyrosine hydroxylase [tyrosine to DOPA] activity
in the autonomic nervous system ; but 4) after several days, decrease NE and 5HT effects on the cerebral cortex and hippocampus.
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Hypothalamus-pituitary-adrenal
gland (HPA) axis

In order to adapt to stress, the body shows resistance to stress. There are
various conditions that are recognized as stress by the body, for example, burns
and other forms of injury to the body, exposure to cold or lowered barometric
pressure, injection of toxic substances, infection, and emotional excitement.
However, the body reaction to these various kinds of stress is somewhat similar,
i.e., the increase of the corticosteroid secretion . In another words, the term "stress"
is any event that elicits increased corticosteroid secretion by the adrenal cortex.
Corticosteroid is the ultimate product of the hypothalamus-anterior pituitary-adrenal
gland axis.
Generally, stress signals from various areas of the brain and sensory
receptors stimulate the hypothalamus and lead to an increase of hypothalamic
noradrenergic neural activity. This, in turn, increases secretion of the corticotropinreleasing factor (CRF) into the hypothalamo-pituitary portal vessels, which is carried
to the anterior pituitary where it causes adrenocorticotropic hormone (ACTH) release
into the systemic circulation. The adrenocorticotropic hormone, in turn, stimulates
the adrenal gland to release glucocorticoids (cortisol and corticosterone) . Cortisol
is more important in humans, whereas corticosterone is the major glucocorticoid in
rodents (Gorbman et al. , 1982). These corticosteroids, the end product of the HPA
axis, are known to impair various aspects of immunocompetence (Besedovsky et
al., 1985). Corticosteroids have also been reported to inhibit IL-2 production and
IL-1 production (Gillis et al., 1979a; 1979b; Snyder and Unanue, 1982; Goodwin et
al., 1986).

Corticosteroids affect lymphocyte recirculation and the generation of

cytotoxic effector cells.

In addition, their remarkable anti-inflammatory potency

depends on features such as inhibition of neutrophil adherence to vascular
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endothelium in an inflammatory area and suppression of monocyte/macrophage
functions such as microbicidal activity and response to lymphokines (Roitt, 1980).
Corticosteroids are known to cause thymic involution (Ciaman, 1972), which
lead, over time, to a potential imbalance in the T-cell pool, ultimately manifested in
the modulation of immune response .
Many reports have attempted to reveal a relationship between the
hypothalamus and immune responsiveness. Keller et al. (1980) used an anterior
hypothalamic lesion in guinea pigs to demonstrate that anterior hypothalamic lesions
diminish the delayed cutaneous response to antigen and also suppress an in vitro
correlate of cell-mediated immunity and lymphocyte stimulation in whole blood.
Kate et al. (1986) mentioned the delayed-type hypersensitivity (DTH) depression in
mice with hypothalamic lesions induced by monosodium glutamate. These works
show that immune responses might be modulated by endogenous hormone
interactions via CRF, ACTH , and adrenocortical hormones.
Recently, ACTH synthesis by immune system cells was reported (Blalock and
Smith, 1980).

These authors reported that human leukocytes expressed an

ACTH-Iike compound during production of interferon (IFNa).

They compared the

leukocyte-derived and pituitary-derived ACTH similarities by their biological activities,
molecular weights, antigenicities, and high-performance liquid chromatography
(HPLC) retention times. Leukocytes not only produced ACTH, but also responded
to CRF.
response.

Dexamethasone (a synthetic glucocorticoid) was reported to block this
Hypophysectomized animals were used to prove that physiologically

significant amounts of ACTH were produced by the immune system .
Taylor (1988) and Taylor et al. (1989) showed an immunosuppressive effect
of T-2 toxin, evaluated the hypothesis that the chemical may additionally have an
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adverse effect on the immune system via the HPA axis, and concluded that
involvement of the adrenal gland in the immunomodulatory activity of T-2 appeared
likely.
Hsieh (1988) examined the HPA-axis influence on immunosuppressive effects
of the organic solvents, benzene and toluene.

Hypothalamic NE concentration

increased, accompanied by an increase of its major metabolite, VMA. At the same
time, an increase in ACTH/corticosterone release was noted in the blood. Thus,
Hsieh concluded that there was at least a partial additive adverse effect on the
immune function via an activated HPA status.
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CHAPTER Ill
MATERIALS AND METHODS
Chemicals

Aflatoxin B, (AFB,) was purchased from Calbiochem-Behring (La Jolla, CA) .
Fluorescein-conjugated monoclonal antibodies (Anti-mouse immunoglobulin , antimouse Thy1 ,2, anti-mouse L3T4, anti-mouse Lyt2) were obtained from Becton
Dickinson (Mountain View, CA). Four mitogens used were concanavalin A (ConA,
Sigma Chemical Co. , St. Louis, MO), lipopolysaccharide (LPS, Sigma). pokeweed
mitogen

(PWM,

Gibco

Laboratories,

Grand

Island,

NY),

and

purified

phytohemagglutinin (PHA, Wellcome Reagents Division , Greensboro, NC) . RPMI
1640 media was obtained from Hyclone Laboratories, Inc. (Logan, UT) and
supplemented as indicated with the specific method (RPMI(+)). Fetal bovine serum
(FBS) was also purchased from Hyclone Laboratories.

An antibiotics mixture

containing penicillin base and streptomycin was obtained from Gibco Laboratories
(Grand Island, NY) . Sheep red blood cells (SRBC) were obtained locally, washed ,
and prepared as indicated later. Guinea pig complement was also obtained from
Gibco. The standard samples for brain amine assays and antioxidant used were
DL-4-hydroxy-3-methoxy-mandelic

acid

(VMA),

[-)-norepinephrine

(NE),

3,4-

hydroxyphenyl acetic acid (DOPAC), 3,4-dihydroxyphenethylamine (Dopamine) (DA).
5-hydroxyindole-3-acetic acid

(5-HIAA) , 4-hydroxy-3-methoxyphenylacetic

acid

(homovanillic acid) (HVA), 5-hydroxytryptamine (serotonin) (5-HT), and L-cysteine,
all of which were obtained from Sigma. Peroxidase-conjugated goat anti-mouse lgM
was

purchased

from

Hyclone.

The

corticotropin

releasing

factor

(CRF)

radioimmunoassay (RIA) kit was obtained from Peninsula Laboratories, Inc.
(Belmont, CA), while the adrenocorticotropic hormone (ACTH) RIA kit and
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corticosterone RIA kit were obtained from Radioassay Systems Laboratories, Inc.
(Carson, CA) . Scintillation cocktail used was prepared in our laboratory as follows :
one liter each of toluene and ethylene glycol monomethyl ether (Fisher Scientific
Co., Fairlawn , NJ) was mixed with 8 g of 2a70 (98% PPO, 2% bis MSB; Research
Products International Co. , Mount Prespect, IL). [Methyi- 3 H]-Thymidine {'H-TdR) and
" Cr-Sodium chromate were purchased from New England Nuclear (Boston, MA).
Animals

Male C57BU6 mice, three weeks old and approximately 14 g in weight
(Simonsen Laboratories, Inc., Gilroy, Ca) were numbered and randomly assigned
to each

experimental group. They were acclimated for two weeks prior to the

experiment in the AAALAC-accredited Laboratory Animal Research Center (LARC)
at Utah State University. Groups of six animals were housed in plastic cages with
corn-cob bedding and received commercial lab chow certified to be mycotoxin free
(Wayne Products, Allied Mills, Chicago, IL} and water ad libitum throughout the
experiment. Room conditions were maintained to keep the temperature at 21±1°C
and relative humidity at 50±10%.

A 12-hr light-dark cycle was maintained.

Adrenalectomy and sham-control operation were performed one week prior to the
AFB, treatments, as required . Operation procedures used were slightly modified
from the method of Waynforth (1980) .

Briefly, the mice were injected with 75

mg/kg of sodium pentobarbital (Authony Products Co., Arcadia CA). The animals
were restrained on a surgical board on their ventral surface , and their back hair and
skin were wetted by a 70% ethyl alcohol solution.

Through a medial incision,

pointed scissors were inserted subcutaneously, and the muscles and connective
tissue near the adrenal gland were torn to obtain entrance into the peritoneal cavity.
Both a curved and a ring forceps were used to remove the adrenal gland from each
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side located near the anterior pole of each kidney. The skin was closed using
stainless clips. The mice were kept warm for about one hour until they regained
consciousness.

Sham operations were done identically except for the removal of

the adrenal glands. After the surgical procedure, adrenalectomized mice were given
physiological saline solution (0.85% NaCI) to drink ad libitum throughout the
experiment.
Aflatoxin B, exposure
Aflatoxin B, was first dissolved in methyl alcohol and its concentration and
purity confirmed by AOAC Official methods of analysis (1984).

Briefly, UV

absorption of diluted AFB, was checked against methanol at 360 nm in a
spectrophotometer (P/N204-04550, Shimazu, Kyoto , Japan) . The concentration was
calculated using molar absorptivity (£=13,400 at 265nm). After the concentration
and amount of AFB, were calculated, the needed amount of AFB, methyl alcohol
solution was measured out into a vial and evaporated to dryness using nitrogen .
Ethyl alcohol was added, stirred, and sonicated. Corn oil was added to this solution
to make the desired doses of AFB ,. i.e., 30, 150, or 750
solution (in 5% ethyl alcohol, 95% corn oil) .

~g

per 10-ml dosing

Dosing solutions were stored in a

refrigerator and homogenized by prolonged stirring and sonication just prior to
dosing. Mice were dosed daily for four weeks with either 0 (vehicle alone), 30, 150,
or 750

~g/kg

of AFB, by oral gavage, using 0.1-ml dosing solution for each 10-g

body weight with the 21 -gauge gavage needle. The groups receiving 0, 30, 150,
and 750

~glkg

daily were named control group (control), low-dose group (low dose),

medium-dose group (med. dose), and high-dose group (high dose), respectively.
Procedures for handling and decontamination of AFB, followed the NIH Guidelines
for the laboratory use of chemical carcinogens and the recommendations of the
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World Health Organization and the International Agency for Research on Cancer
(Castegnaro et al., 1981). All animals during AFB, treatment were housed in selfcontained laminar flow hoods (Dual Flow Vinyl Isolator, model H5500, Lab Products,
Maywood, NJ).
Experimental design
Experiments were performed in two separate sets.

In Set I, non-

adrenalectomized animals were used with four-dose levels of AFB ,. including the
vehicle control group; in Set II, adrenalectomized animals were used along with
sham-operated and no-operated controls. Set II experiment consisted of two dose
levels, including a vehicle control. Since all assays could not be performed on the
same animal, three separate phases of experiments were employed in each set.
Phase I groups were used for determining lymphocyte function and brain amine
concentrations.

Phase II groups were used for evaluating

AFB , in brain and plasma samples.

hormonal effects of

Phase Ill groups were prepared for

immunological evaluation after the SRBC challenge.
During the four-week AFB, exposure, body weight and consumption of feed
and water were checked daily.

All mice were weighed and sacrificed by

decapitation one day after the last exposure. In the phase I experiment, the spleen,
liver, kidney , thymus, and adrenal glands were quickly excised, trimmed, and
weighed. Blood was sampled in EDTANa.,-coated glass tubes. Total red and white
blood cells were counted using a model D-2 Automatic Blood Cell Counter (Coulter
Electronics, Inc. , Hialeah , FL).
samples were used.

For red blood-cell counting, 50,000-times-diluted

For white blood-cell counting, an erythrocyte-lysing solution

was used, and 500-times-diluted sample was prepared.
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Evaluation of immune responses after
Aflatoxin B, treatment

Isolation and preparation of
splenic lymphocytes
Spleens were aseptically removed from mice, weighed, and maintained in
RPMI 1640 media supplemented with 5% heat-inactivated fetal bovine serum (FBS),
100 units of penicillin and 100

~g

mercaptoethnol (ME), (RPMI 1640(+)).

of streptomycin per ml, and 50

~M

Spleens and media were transferred to

sterile plastic bags. They were mashed in a Stomacher Lab Blender (STOM 80,
Tekmar Company, Cincinnati, OH) , producing monocellular splenic cell suspensions.
The suspensions were then transferred back into 15-ml sterile centrifuge tubes and
the debris allowed to settle for 5 min .

Supernatants were transferred into new

sterile tubes. The cell concentration was adjusted to 5x1 O' cells/ml using RPM I(+)
after counting an aliquot with a 0-2 cell counter. The cell number was reconfirmed
in the diluted mixture after plating the culture wells (see below) .

For several

experiments (see following methods), erythrocytes were lysed using hypotonic shock
(see detail in Fig. A-1 . in the APPENDIX). The cell concentration was adjusted
similarly after separating unnucleated cells.
Flow cvtometry
Phenotyping of splenic cells was performed by using a

Fluorescence

Activated Cell Sorter (FAGS) (model EPICS V, Coulter Instrument. Co. , Hialeah, FL) .
Three tubes were prepared for each sample.

A

4-~1

aliquot of fluorescein-

conjugated anti-mouse Thy1 .2 antibody; phycoerythrin-conjugated anti-mouse L3T4
and fluorescein-conjugated anti-mouse Lyt2 antibodies; and fluorescein-conjugated
anti-mouse immunoglobulin antibodies were added to the three tubes, respectively,
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with 100 ~I of water-lysed splenocy1es (1 O' cells) added to each tube, mixed
thoroughly, and incubated for 30 min at room temperature in a dark box.

After

incubation, 500 iJ.1 of RPMI were added to each tube and the resulting cell
suspension analyzed by FAGS using appropriate protocols suggested by the
manufacturer.

Flow cy1ometry analyzes phenotype on the basis of a cell's size,

granularity, and fluorescence. The examples of flow cy1ometry analysis profile are
shown in Fig . A-2. in the APPENDIX.
Cell-proliferation tests
Mitogen-induced and mixed lymphocy1e-induced cell-proliferation evaluation
tests were performed using ' H-TdR uptake as an indicator.

After the following

procedures of cell culturing, incubated cells were harvested on glass fiber filters
(#30 Glass, Schleicher and Schuell Inc., Keene NH) using a Brandel model M-12
cell

harvester

(Biomedical

Research

and

Development

Laboratories

Inc.,

Gaithersberg, MD). Filters were dried overnight at room temperature and punched
out in 7-ml plastic scintillation vials (Fisher, Scientific Co., Fairlawn, NJ). Three ml
of scintillator were added to each vial. Tritium activity of samples was determined
by a Packard model Tri-Carb 2660 liquid scintillation counter (Packard Instrument
Company, Inc., Downers Grobe, IL).
Mitogen-induced responses: Fifty ~I of splenic cell suspension (0.25x1 O' cells) were
seeded (the pre-experiment results to decide the inoculum size are shown in Fig.
A-3. in the APPENDIX) in triplicate wells of microtest tissue-culture plates (Corning,
Corning, NY), with 50

~I

of media containing ConA, LPS, PWM, PHA, or no

mitogen. The optimal concentration used was determined for each mitogen in a
pre-experiment (the results of pre-experiment are depicted in Fig. A-4. in the
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APPENDIX).
were 6.25
50

~I

The utilized optimal concentrations of ConA, LPS, PWM, and PHA

~g /ml ,

25

~g /ml,

1.25%, and 3.125

~g/ml,

respectively, with an additional

of RPMI added to each well to adjust the volume.

incubated 48 hr at 37°C in humidified air with 4% C02 •

These plates were

Each culture was then

pulsed by adding 0.5 ~Ci (18.5 kBq)/50 ~I of 'H-TdR in RPMI(+) and cultured
additional 6 hr.

The cells were harvested and counted by a liquid-scintillation

counter as described above.
Mixed lymphocyte culture (MLC) responses: A one-way, mixed lymphocyte culture
(MLC) assay was performed as described previously (Hsieh et al., 1989).
Mitomycin C-treated YAC-1 mouse lymphoma cells (Moloney virus induced Tlymphoma cells from NSn mice strain) (American Tissue Culture Collection, ATCC,
Rockville, MD) were used as stimulator. The responder-stimulator ratio was decided
in a pre-experiment.

YAC-1 cells were previously incubated and harvested by

centrifugation at 1,000 rpm 5 min just before use. Fifty

~g

of mitomycin C were

added to every 20 million cells in 1-ml media. After a 1-hr incubation at 37°C, the
cells were washed three times using RPM I media. Cell concentration was adjusted
to 5x1 o• cells/mi. A suspension containing 50 ~I of responder cells, stimulator cells,
and additional 50
culture, 50

~I

~I

of RPMI(+) was cultured in a 96-well plate. For the control

of RPMI were added instead of stimulator cells. The cultures were

then incubated for 72 hr at 37°C in humidified air with 4% C02 followed by a 24hr 3 H-TdR pulse.

The cells were harvested and counted by a liquid scintillation

counter as described above.
Natural killer INK) cell assay
The cytolytic activity of natural killer (NK) cells against "Cr labeled YAC-1
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target cells was measured as described by Grabstein (1980). YAC-1 cells, prepared
and checked for their viability using trypan blue, were centrifuged at 250xg (1 ,000
rpm) for 5 min in a 50-ml centrifuged tube. The supernatant was discarded, and
250 11Ci (9 .25 mBq) of ["Cr]-Sodium chromate in sterile saline (New England
Nuclear, Boston, MA) were added, after which the mixture was incubated for 1 hr
at 37°C. Five ml of FBS were added after incubation, and cells were resuspended.
Excess "Cr in FBS was removed after centrifugation . Labeled YAC-1 cells were
washed two times using RPMI and resuspended in RPMI(+).

Cell concentration

was adjusted to 1x1 O' cells/ml and seeded 100 Ill in 96-well round-bottom plates
7

(Corning, Corning, NY). One hundred Ill of responder cells (1 x1 0 cells/ml cone.),
positive control (0 .5% saponin for checking maximum release), or negative control
(RPMI(+) media for checking spontaneous release) were co-cultured with labeled
target cells for 4 hr at 37°C. At the end of the incubation period, the plates were
centrifuged at 250xg (1 ,000 rpm) for 10 min. Being careful not to disturb the cell
pellet, 100 Ill of the supernatant were removed from each well and placed in plastic
tubes. Radioactivity was measured by a model 578

r

scintillation counter (Packard

Instrument Company, Inc., Downers Grove, IL). The triplicate mean was used to
calculate the percentage of "Cr release as described earlier (Grabstein, 1980).
lnterleukin-2 IIL-2) assay
lnterleukin-2 production was determined by bio-assay system using an IL-2
dependent cell line (HT-2; BALB/c origin, established by Watson, 1979). A modified
procedure of Gillis et al. (1978) was used. The HT-2 cell line was maintained in
RPMI 1640 media, supplemented with 10% heat-inactivated fetal bovine serum
(FBS), 100 units of penicillin and 100 llg of streptomycin per ml, 50 11M
mercaptoethanol, and 5 units/ml of rat spleen cell IL-2 (Sigma Chemical Co., St.

32
Louis, MO).
Two million splenic lymphocytes obtained from the treated mice were
cultured in 1 ml of RPMI1640 media, supplemented with 10% heat-inactivated FBS,
100 units of penicillin and 100 J.Lg of streptomycin per ml, and 50 J.LM ME, with or
without ConA at the concentration of 2 J.Lg/ml to stimulate IL-2 production in 24 well
plates (Corning, Corning, NY) . The culture supernatants were collected after a 48hr incubation and stored at -70°C.
Prior to the IL-2 bio-assay, cultured HT-2 cells were washed three times with
4

RPMI and resuspended at a concentration of 8x10 cells/ml in RPMI 1640 media,
supplemented with 2% heat-inactivated FBS, 100 units of penicillin and 100 J.Lg of
streptomycin per ml, and 50 J.LM ME. Fifty Jll of the above culture supernatant, 50
Jll of HT-2 cells, and additional 50 J.LI of RPMI(+) were seeded in duplicate in 96well plates.

Several dilutions of IL-2 standards (rat spleen cell IL-2, Sigma) were

also prepared and cultured at the same time. The cultures were incubated for 24
hr at 3?0C in humidified air with 4% CO,. ['H)-TdR (0.5 J.LCi) in 50 Jll of RPMI(+)
was added to each well, and incubation was continued for another 4 hr, after which
the cells were harvested and counted by a liquid scintillation counter as described
above.
Antibody production
Antibody-producing ability of AFB,-treated animals against SRBC challenge
was evaluated using a plaque-forming cell assay (PFC) and enzyme-linked
immunosorbent assay (ELISA). Mice were sensitized by the T-dependent antigen
SRBC five days prior to their being sacrificed.

SRBCs (ca. 5x1 o' cells in 0.2-ml

sterile saline) were injected intraperitoneally. Results of pre-experiments, after which
optimal conditions were achieved, are depicted in Fig. A-5. and Fig. A-6. in the
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APPENDIX.
Hemolytic

plaque

assay:

The

modified

plaque-detection

method

using

microchambers (Cunningham and Szenbeg, 1968) was performed to evaluate the
ability of splenic lymphocytes in test mice to respond to an antigenic challenge by
SRBC. Since cells must be fresh for this test, cell counting was performed after the
assay.

Freshly-prepared SRBC suspension (1 0% SRBC (v/v)), guinea pig

complement, and splenic cell suspension (45%, 10%, and 45%, respectively) were
mixed thoroughly. Aliquot of the mixtures was seeded in Cunningham glass-slide
chambers and edges sealed with a paraffin/vaseline mixture. Alter a 1-hr incubation
at 37°C, the hemolytic plaques were counted using a low power microscope (40x)
connected to a projector, and the results were expressed as plaques-per-one-millionsplenic-lymphocytes and plaques-per-whole-spleen .
Enzyme-linked immunosorbent assay (ELISA): The antibody titer for immunoglobulin
M (lgM) in plasma samples was determined by an indirect, enzyme-linked
immunosorbent assay (ELISA) (Voller et al., 1979).

Ninety-six well polystyrene

microtissue culture plates (Dynatech Laboratories, Inc., Alexandria, VA) were coated
with 150 J.!l of SRBC ghosts (prepared in our laboratory as described by Hanahan
and Ekholm, 1974) in 0.06 M, pH 9.6, carbonate buffer by a 2-hr incubation at
37°C. The coating solution contained 5 ).!g/ml protein (SRBC ghost). Following the
incubation, plates were washed five times with 0.025 M phosphate-buffered saline
containing 0.05% Tween 20 (PBS-Tween). Test plasma samples were diluted 100
times by PBS-Tween. One hundred J.!l of diluted plasma sample was pipetted to
the well and incubated for 2 hr at 37°C. The wells were then washed ten times
with distilled water. Peroxidase-conjugated goat anti-mouse lgM, diluted 500 times
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by PBS-Tween, was added in a 100-J.LI volume to the wells and incubated 2 hr at
3JCC.

The wells were washed as before, and 100 Jll of substrate (o-

phenylenediamine, 0.4 mg/ml, in 0.01 M citrate buffer, pH 5 with 0.012% H,02 )
was added to each well.

After a 15-min incubation at room temperature, the

reaction was stopped by adding 50 Jll of 1 N HCI. The optical density at 490-nm
wave length was measured via a model EL309 microplate autoreader (Bio-Tek
Instruments, Inc., Burlington, VT).
Assay of neurotransmitters and
their metabolites

Processing of hypothalamus
Following four weeks of AFB, exposure , the animals were decapitated, and
the hypothalamuses were rapidly dissected on an ice-cold glass plate (Giowinski
and Iversen,

1966).

To avoid possible diurnal alteration of brain amine

concentration, all animals were sacrificed between 9:00 and 12:00 a.m.

Each

hypothalamus was weighed in tared tubes containing 0.4 ml of ice-cold 0.05 M
perchloric acid (containing 0.1% cysteine to prevent oxidation of monoamine
neurotransmitters). After a 1-min sonication in an ice bath, the samples were frozen
on dryice and stored at -70°C until the following procedure was done.

Each

hypothalamus was homogenized individually and sonicated 2 min in an ice bath .
Homogenates were centrifuged at 11,000xg (1 0,000 rpm) for 30 min at 4°C. The
supernatant was filtered through 0.2 Jlm of regenerated cellulose membrane filter
(RC 58, Schleicher and Schnell, Inc., Keene, NH) by centrifugation at 250xg (1000
rpm} for 3 min. Filtrates were stored at -70°C until analysis by high performance
liquid chromatography (HPLC) as follows.
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Analytical system
The stored filtrates were thawed in an ice bath just before analysis and then
injected directly into a high-performance liquid chromatography (HPLC) system. The
HPLC system consisted of a model LC-50 electrochemical analyzer, a model LC3A amphoteric detector, a model LC-22A temperature controller, and a biophase
ODS-reversed phase column (Bioanalytical System, Inc., West Lafayette, IN). The
mobile phase was prepared according to the method described by Mayer and
Shoup (1983).

The instrument settings were: flow rate 1.5 ml/min , column

temperature 30°C, detector potential +0.7 V, and controller 10 nA, full scale . The
pH and tetrahydrofuran concentration of the mobil phase were 3.0 and 1.5 percent,
respectively.

Appropriate standards containing VMA, NE, DOPAC, DA, 5-HIAA,

HVA, and 5-HT were used and concentration in the injected samples calculated by
an integrator (3390A reporting integrator, Hewlett-Packard, Avondale, PA).

The

amount of each amine or metabolite in the sample were subsequently computed in
a gram of wet tissue.
Endocrine hormone measurements

To control the variability endocrine hormone concentrations throughout the
day, samples were obtained between 9:00 a.m. and 12:00 a.m. for all animals of
set I and II. Kits for AlAs were used as directed with slight modifications.
Corticotropin releasing factor (CRFl
Following four weeks of AFB, exposure , the animals were decapitated, and
the hypothalamus and cerebral cortex were rapidly dissected on an ice-cooled glass
plate (Giowinski and Iverson, 1966). Samples were weighed in tared tubes, frozen
on dryice immediately, and stored at -70°C until the following procedure was carried
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out.

The extraction of CRF from brain tissue followed the modified method of

Fischman and Moldow (1982).

After sample tubes were placed in an ice bath ,

300 Ill of distilled water for hypothalamus or 400 Ill for cerebral cortex were added
to the tubes.

Using a glass rod, the tissues were homogenized and kept in a

boiling water bath for 5 min and sonicated for 2.5 min. These tubes were then kept
in an ice bath, chilled, and centrifuged at 11 ,OOOxg (1 0,000 rpm) for 30 min at 4°C.
Supernatants were collected and stored at -70°C.
Lyophilized reagent was reconstituted with a kit-supplied diluent buffer.
Ninety Ill of diluent buffer, various amounts of standards, or sample extracts were
added to polypropyrene tube.

Next, 90 Ill of

125

1-CRF were added to each tube,

followed by 90 Ill of anti-CRF antibody. Contents were mixed well and incubated
for 12 hr at 4°C. After incubation, 90 Ill of goat anti-rabbit-lgG and normal rabbit
serum were added to precipitate and mixed well. After a 2-hr incubation at room
temperature, 0.55 ml of buffer were added to each tube and vortex mixed.
Supernatants were aspirated out after centrifugation

(3,000 rpm , 15 min) .

Radioactivity of the pellet was measured by a gamma scintillation counter (model
578, Packard Instrument Company, Inc., Downers Grove, IL). Data were calculated
using a standard curve (Fig. A-?a. in APPENDIX).
Adrenocorticotropic hormone {ACTHl
Blood was collected in chilled tubes coated with EDTA disodium salt and
stored in an ice bath.

Plasma was separated by centrifugation (2,000xg [3 ,000

rpm], 15 min) within an hour from sample collection .

Samples were frozen

immediately and stored at -70°C until analysis.
Lyophilized reagents were reconstituted with kit-supplied water and kept for
15 min at 4°C before use.

Ninety Ill of diluent, various amounts of ACTH
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~I

standards, or plasma samples were added to the glass test tubes. Next, 90

of

"'1-ACTH were added to each tube, followed by 90 ~I of anti-ACTH antibody.
Contents were mixed well and incubated 16 hr at 4°C. After incubation, 0.45 ml
of precipitation solution (warmed to room temperature) were added to each tube and
mixed well.

The tubes were centrifuged for 15 min at 2,000xg (3,000 rpm), and

supernatants were removed by aspiration .

The radioactivity of the pellets was

measured as described above. Data were calculated using a standard curve (Fig .
A-7b. in the APPENDIX).
Corticosterone
Same plasma samples as the ACTH assay were diluted 200 times by diluent
provided with the kit and used for this assay.
All reagents were brought to room temperature prior to use. An aliquot of
90

~I

of diluent buffer, various amounts of corticosterone standards, or diluted

plasma samples (1 :200) were added to glass test tubes.
corticosterone was added to each tube, followed by 90

~I

Next, 90 ~I of

125

1-

of anti -corticosterone

antibody. Contents were mixed well and incubated 2 hr at room temperature. After
incubation, 0.45 ml of precipitation solution (warmed to room temperature) were
added to each tube and mixed well. The tubes' contents were centrifuged for 15
min at 2,000xg (3,000 rpm), after which the supernatants were removed by
aspiration. Radioactivity of the pellets was measured as described above.

Data

were calculated using a standard curve (Fig. A-7c. in the APPENDIX) .
Statistical analysis

Results are expressed as the mean ± standard error (SE).

Data were

analyzed using a one-way analysis of variance (ANOVA). When F ratios indicated
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a significant difference , Fisher's least significant differences (LSD) test was applied
for intergroup comparisons. The p values are indicated in respective results or
tables and figures .
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CHAPTER IV
RESULTS
Results obtained from Set I and Set II experiments are separately described
in this chapter. Set I experiments, using non-operated animals, are presented under
the heading, "Effects of AFB, on C57BU6 mice," whereas Set II experiments, using
adrenalectomized and appropriate

control

animals,

are

named "Effects of

adrenalectomy on the response of C57BU6 mice to AFB,."
Set I. Effects of AFB, on C57BU6 mice

The results of the experiments using non-operated mice, exposed to AFB,
for four weeks daily at four dosing levels (containing vehicle control) , are described
below.
No significant effects were observed on body weights (TABLE IV-1), water
consumption, or feed consumption (data not shown) .

No gross lesions were

observed on the organs of any mice in all groups.
Organ weights. erythrocyte counts.
and leukocyte counts
Organ weights, erythrocyte counts, and leukocyte counts are depicted in
TABLE IV-2. No significant changes were observed in selected organ weights and
erythrocyte counts.

Leukocyte counts were decreased in a dose-related manner,

however, significant differences were seen at medium (0 .15 mg/kg/day) and high
doses (0.75 mglkg/day) of AFB, only.
Spleen-cell phenotype
The results of flow analysis are presented in TABLE IV-3.

Significant

changes were observed in the percentage of B cells that reacted to the anti-mouse
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TABLE IV-1
EFFECTS OF AFB, FOUR-WEEK EXPOSURE ON
BODY WEIGHT GAIN OF C57BU6 MICE ' 1
AFB,
Initial body weight
(g)
(mg/kg/day)

0
0.03
0.15
0.75

20.0 + 0.4
20.4 :;: 0.6
19.6:;: 0.3
19.6 :±: 0.5

Final body weight
(g)

22.1 + 0.6
22.9:;: 0.7
22.1 0.2
22.6 :±: 0.6

+

1); Values are given as mean± SE (n=6)

gain
(%)
10.2 + 2.1
11 .9:;: 3.0
12.8 1.5
15.9 :±: 3.6

+

TABLE IV-2
EFFECTS OF AFB , FOUR-WEEK EXPOSURE ON ORGAN WEIGHTS
AND PERIPHERAL BLOOD COUNTING OF C57BU6 MICE ' 1
AFB,

Organ Weight
Liver

Kidney
Thymus
(mg/100g b.w.)

(mglkg/d)

0
0.03
0.15
0.75

5044 ± 74
4823 + 188
4721 :;: 217
4849
85

±:

1265 ± 14
1328 ± 37
1310 + 38
21
1184

±:

1) ; Values are given as mean

197 ± 12
182 ± 11
220 + 21
188
8

±:

± SE

(n=6)

Significantly different from control (p<0.05)

Peripheral blood cell
Spleen
271 ± 111
271 ± 6
297 + 11
281
11

±:

Erythrocyte
(x 106/mm 3 )

Leukocyte
(x 103/mm 3 )

9.66 ±
8.99 +
9.19:;:
9.19

1.98 ±
1.50 +
1.34:;:
1.27

±:

0.18
0.25
0.25
0.25

±:

0.16
0.12
0.19.
0.21.

TABLE IV-3
EFFECTS OF AFB, FOUR -WEEK EXPOSURE ON PHENOTYPIC DISTRIBUTION OF
SPLENOCYTES OF C57BU6 MICE ANALYZED BY FLOW CYTOMETRY ' 1
AFB,
(mglkg/d)
0

0.03
0.15
0.75

Thy1
(total T)

L3T4
(Helper T)

Ly12
(Sup. & Cy1. T)

lg
(8 all)

L3T4/Ly12
(ratio)

23.8 + 1.3
27.1 0.9
24.1
1.0
21 .3 :±2.0

15.2
15.6
13.9
12.1

11 .2
13.3
11 .0
9.9

29.0 + 2.2
19.1 0.2"
20.3 0.5'*
23.8 :± 1.3'

1.36 + 0.03
1.18 0.04'
1.29 0.05
1.24 :± 0.05

+
+

+ 0.3
:±o.5
+ 0.6
:± o.a··

+ 0.4
:±o.5
+ 0.6
:±o.7

1) ; Values represent% of population of total splenic cells .
Values are given as mean ± SE (n=6).
Significantly different from control (p<0.05)
Significantly different from control (p<0.01)

+
+

+
+
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immunoglobulin antibody and occurred in a dose-related fashion. Another significant
decrease was observed in the percentage of helper T cell, which reacted to the cellsurface differentiation antigen L3T4 monoclonal antibody.
Cell -proliferation test
Mitogen-induced responses :

Mitogen-induced splenic lymphocyte proliferation,

indicated by 'H-TdR uptake, is presented in Fig. IV-1 . The four different mitogens
used were :

ConA (helper T cell and suppressor T cell specific}, LPS (8 cell

specific), PWM (non -specific}, and PHA (helper T cell specific) .

Dose-related

decreases in response to ConA, LPS, and PWM were observed. The response to
PHA, however, was not effected.
Mixed lymphocyte culture (MLC) responses : The proliferative response of splenic
lymphocyte in response to co-cultured mitomycin C treated YAC-1 cells, indicated
by ' H-TdR uptake , is presented in TABLE IV-4.

No significant effects of AFB,

treatment were observed in the stimulation index (S.I.).
Natural killer INK) cell assay
The cell-mediated cytolytic response of NK cells was measured using " Crlabelled YAC-1 cells as a target.

The results shown here are percent release,

which is calculated as the sample's chromium release against the maximum release
of chromium. The results of NK cell assay presented in TABLE IV-5 indicated no
significant effect of AFB, exposure at any dose level.
IL-2 production
The ability of splenic cells to produce IL-2 was examined using 'H-TdR
uptake of IL-2 dependent cells (HT-2 cell line).

Standard 11-2 samples were
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Fig. IV-1.
Effects of four-week AFB, exposure on proliferative
responses to mitogenic substances of C57BU6 mice splenic
lymphocyte measured by ' H-TdR uptake. Values are given as mean
± SE (n=6) . Asterisks indicate the significant difference produced by
AFB, treatment when compared to control group (• , p<0.05; ••
p<0.01 ).
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TABLE IV-4
EFFECTS OF AFB, FOUR-WEEK EXPOSURE ON MIXED LYMPHOCYTE
RESPONSE OF C57BU6 MICE MEASURED BY MLC ASSAY ' 1
AFB,
(mg/kg/d)

0
0.03
0.15
0.75

' H-TdR uptake by
cells without stimulator
(dpm/10' cells)
10472 + 1392
10098
833
1406
9805
7888 ±: 942

+
+

3
H-TdR uptake by
cells with stimulator
(dpm/1 O' cells)

57806
57196
55959
53191

+5502
+"1736
+"2740
±:4742

1); Values are given as mean± SE (n=6)

S.l.

5.87 + 0.74
0.51
5.89
6.33
0.78
7.07 ±: 0.63

+
+
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TABLE IV-5
EFFECTS OF AFB, FOUR-WEEK EXPOSURE ON NATURAL KILLER CELL ACTIVITY
OF C57BU6 MICE MEASURED BY " Cr RELEASE ASSAY ' 121
AFB, dose
(mg/kg/day)

Percent " Cr release

0
0.03
0.15
0.75

(%)

25.27 +
27.06:;:
27.35:;:
25.46

1.29
0.72
0.74
1.25

±

1); Values are given as mean .:t SE (n=6)
(sample " Cr release) - (spontaneous " Cr release)
2); % release = --------------------------------------------------------------------------- X 100
(maximal " Cr release) - (spontaneous " Cr release)
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prepared and co-cultured with HT-2 cells at the same time as the assay.

The

standard curve (Fig. IV-2) indicates the HT-2 cells' 'H-TdR uptake increase in IL-2
concentration in a related manner. Results were calculated using a standard curve
to produce IL-2 units by one-million splenic cells, as shown in Fig. IV-3. A doserelated decrease in IL-2 production was observed. Similar effects were observed,
both in ConA stimulated (Fig. IV-3b.) culture supernatants and non-stimulated culture
supernatants used (Fig. IV-3a.) for IL-2 production assay.
Antibody produ ction
Hemolytic-plaque counting : The primary anti-SRBC antibody producing cell number
(T-cell dependent) was evaluated five days after the SRBC challenge. The results
shown in Fig. IV-4a. reveal a dose-related reduction of plaque-forming cells (PFC)
per one-million splenic cells ; the same tendency was observed in PFC numbers per
spleen (Fig. IV-4b.). The reductions were statistically significant at p<0.05 or p<0.01
at the two high-dose levels of AFB,.
ELISA: Anti-SRBC antibody (lgM) titer in plasma from the animals five days after
the SRBC challenge was determined by ELISA. The optical density values obtained
at 490 nm and measured by spectrophotometer are presented in Fig . IV-5.
Decreased titer in a dose-related fashion was observed.

Statistically significant

decreases were observed in groups treated with medium- and high-dose levels of
AFB, (p<0.01).
Endocrine hormones
Corticotropin releasing factor (CRF) :

Corticotropin releasing factor (CRF) in the

hypothalamus and in the cerebral cortex was assayed by radioimmunoassay (RIA) .
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Concentration of CRF in the hypothalamus (Fig. IV-6a.) showed no significant
difference between control and treated groups, while concentration of CRF in the
cerebral cortex was elevated in AFB, treated groups (p<0.05).
Adrenocorticotropic hormone (ACTH):

The plasma concentration of ACTH was

determined by RIA. Results (Fig. IV-7.) showed a marginal dose-related increase
in ACTH concentration, but these changes were not statistically significant.
Corticosterone: The plasma concentration of corticosterone was measured by RIA.
Results depicted in Fig . IV-8. show no dose-related changes.

A slight (but not

significant) decrease in corticosterone concentration was observed in the group
treated with the lowest dose of AFB,.
Brain amines
Concentrations of brain biogenic amines (NE, DA, and 5-HT) and their major
metabolites (DOPAC, HVA, and 5-HIAA) in the hypothalamus were determined by
HPLC as shown in Fig. IV-9. There were no significant changes in NE
concentration . Since the metabolite of NE, VMA concentration was non-detectable
in most of the samples, the results are not illustrated. No AFB, treatment-related
effect was observed on DA or its metabolites DOPAC. The level of HVA decreased
slightly (non-significant statistically) in the group treated with the highest dose of
AFB,.

The intermediate levels of AFB, exposure, however, caused no effect on

HVA concentrations. The concentration of 5-HT and its metabolite HIAA showed a
marginal decrease in the high-dose group, but no statistical significance was
observed.
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Set II. Effects of adrenalectomy
on the response of C57BU6 mice
to AFB,

Rsults

of the

experiments

using

non-operated,

sham-operated,

and

adrenalectomized animals, which were exposed to AFB, daily over the period of four
weeks with two dosing levels (including vehicle control) are described below. Only
one AFB, dose level was selected, the same amount as the high dose in Set I
experiments. The abbreviated names used here in tables and figures to distinguish
the six experimental groups are: N.C.--non-operated animal control group; N.H.-non-operated animal group treated with high-dose AFB,; S.C.--sham-operated animal
control group; S.H.--sham-operated animal group treated with high-dose AFB,; A.C. -adrenalectomized animal control group; and A.H.- -adrenalectomized animal group
treated with high-dose AFB,.
No significant effects were observed in body weight gain (TABLE IV-6),
water consumption, and feed consumption (data not shown). No gross lesions were
observed on the organs of any mice in all treatment groups.
Organ weights. erythrocyte counts,
and leukocyte counts
Organ weights, erythrocyte counts, and leukocyte counts are depicted in
TABLE IV-7. No significant changes were observed in organ weight and blood-cell
counting. Thymus and spleen showed hypertrophy in adrenalectomized animals.
Spleen-cell phenotype
The results of flow analysis are presented in TABLE IV-8.

Significant

changes were observed in suppressor and cytotoxic T cells, which responded to the
Lyt2 antibody in the adrenalectomized group; the L3T4/Lyt2 ratio was slightly altered
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TABLE IV-6
EFFECTS OF ADRENALECTOMY ON BODY WEIGHT GAIN OF
C57BU6 MICE FOLLOWING FOUR-WEEK AFB , EXPOSURE ' 1

Exp.
group
N.C.
N.H .
S.C.
S.H.
A.C.
A.H.

Initial body weight
(g)
19.3 + 0.4
19.1 + 0.5
19.1 + 0.4
19.7+0.4
19.8 ~ 0.7
19.2 0.7

±

Final body weight
(g)
20.9
20.7
20.5
20.7
20.6
20.3

+
+
+
~

0.5
0.6
0.6
0.4
0.7
± 0.8

±

1); Values are given as mean ± SE (n=6)

gain
(%)

8.5
8.5
7.7
4.9
4.4
5.8

+ 1.2

±
1.5
+ 1.7
~ 1.0
±1.5

± 2.6

TABLE IV-7
EFFECTS OF ADRENALECTOMY ON ORGAN WEIGHTS AND PERIPHERAL BLOOD
COUNTING OF C57BU6 MICE FOLLOWING FOUR-WEEK AFB , EXPOSURE

Exp.
group

Organ Weight
Liver

N.C.
N.H.
S.C.
S.H.
A.C.
A. H.

Kidney
Thymus
(mg/100g b.w.)

5144 + 85
4678
127
4934 + 110
4931
100
4848
96
4943
142

±:

+
+
±:

1305 ± 30
1240 + 14
1342
31
1242 + 21
43
1263
1213
36

±:

+
±:

203 ± 6
211 ± 10
221 ± 7
208 + 9
255
25
273
19

+
±:

1) ; Values are given as mean ± SE (n=6)

Peripheral blood cell
Spleen

Erythrocyte
(x 1O'/mm')

Leukocyte
(x 103 /mm' )

269 + 8
262
3
8
255
270
9
335
12
323 ± 27

8.95 + 0.18
8.40
0.25
8.70
0.26
8.16 + 0.36
9.23
0.35
8.49
0.20

2.68 + 0.20
2.37
0.21
3.23 + 0.20
3.32
0.23
3.22
0.20
3.16 ± 0.09

+
+
+
±:

+
±:

+
±:

±:

+
±:

TABLE IV-8
EFFECTS OF ADRENALECTOMY ON PHENOTYPIC DISTRIBUTION OF
SPLENOCYTES OF C57BU6 MICE FOLLOWING FOUR -WEEK
AFB , EXPOSURE ANALYZED BY FLOW CYTOMETRY ' 1
EXP.
group
N.C.
N.H.
S.C.
S.H.
A.C.
A.H .

Thy1 .2
(total T)

L3T4
(Helper T)

Ly12
(Sup. & Cyt. T)

lg
(B all)

L3T4/Ly12
(ratio)

31 .0
31 .7
32.8
36.6
33.0
33.9

19.1
18.0
17.6
18.7
17.2
17.9

14.6
15.5
15.6
15.6
14. 5
16.4

28.3 + 1.1
31.0+"1.4
28.8 1.5
28.4 1.6
33.2 1.0
31.9 :±:0.7

1.32
1.17
1.13
1.20
1.20
1.09

+1 .3

+1.3

:±: 1.1
± 1.1
+ 2.6
:±:o.7

+ 0.4
:±:o.5
±0.6
±0.6
+ 0.6
:±:o.5

+ 0.3
:±: 0.6
+ 0.2
:±:o.3
+ 0.8
:±: o.5*

+
+
+

+
:±:
±
+

0.03
0.03*
0.04
0.04
0.07
:±: 0.03

+

1) ; Values represent% of population of total splenic cells.
Values are given as mean ± SE (n=6)
Significantly different from control (p<0.05)

0>
0
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in the non-operated group.
Cell-proliferation test
Mitogen-induced responses :

Mitogen-induced splenic lymphocyte proliferation,

indicated by 'H-TdR uptake, is presented in Fig. IV-10. Aflatoxin B, decreased the
lymphocyte response to ConA, LPS, and PWM. The response to PHA, however,
was not affected, similar to the observation in Set I experiments. A decrease of
lymphocyte proliferation without a mitogenic stimulation was also observed.
Adrenalectomy did not have any effect on the splenic lymphocyte response to
mitogens.
Mixed lymphocyte culture (MLC) responses: The proliferative response of splenic
lymphocytes in the presence of mitomycin C treated YAC-1 cells, indicated by ' HTdR uptake, is presented in TABLE IV-9.

No significant effect of AFB, was

observed in the stimulation index (S.I.) in any treatment. Adrenalectomy also did
not have any effect on the MLC responses.
Natural killer cell assay
The results of the NK cell assay are presented in TABLE IV-10. and indicate
no significant effect of AFB, exposure in either group.

No effect of either

adrenalectomy or sham-operation was observed on this parameter.
IL-2 production
The results of IL-2 production in non-operated and operated animals, with or
without AFB, exposure, are shown in Fig. IV-11. Aflatoxin B, exposure decreased
the IL-2 production in all treatment groups. Adrenalectomized animals produced a
significantly lesser amount of IL-2, compared with cells derived from non-operated
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Fig. IV-10.
Effect of adrenalectomy on proliferative responses to
mitogenic substances of C57BU6 mice splenic lymphocyte following
four-week AFB, exposure measured by ' H-TdR uptake . Values are
given as mean ± SE (n=6).
Asterisks indicate the si gnificant
difference produced by AFB, treatment when compared to its
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TABLE IV-9
EFFECTS OF ADRENALECTOMY ON MIXED LYMPHOCYTE RESPONSE OF
C57BU6 MICE FOLLOWING FOUR-WEEK AFB , EXPOSURE
MEASURED BY MLC ASSAY ' 1
Exp.
group
N.C.
N.H.
S.C.
S.H .
A. C.
A.H.

' H-TdR uptake by
cells without stimulator
(dpm/1 o• cells)
15484 +
12331 :;:
15985 ±
11899 +
17621:;:
13325 ±

2354
1628
1254
865
1208
1497

S.l.

' H-TdR uptake by
cells with stimulator
(dpm/106 cells)
59357
48663
69287
51615
59294
49958

+7240
:;:3119
±6467
+4304
±3814
±4009

1); Values are given as mean ± SE (n;6)

4.03
4.42
4.35
4.32
3.53
3.85

+0.39
±0.72
+0.32
:;:0.12
:;:0.47
±0.18

64

TABLE IV-10
EFFECTS OF ADRENALECTOMY ON NATURAL KILLER CELL ACTIVITY OF
C57BU6 FOLLOWING FOUR-WEEK AFB, EXPOSURE MICE
MEASURED BY " Cr RELEASE ASSAY ' 121
Experimental
group

Percent " Cr release
(%)

N.C.
N.H.
S.C.
S.H.

A.C.

A.H.

27.91 + 0.93
26.43
0.89
29.00 + 1.08
26.94 :;: 1.35
33.14
1.07
32.12
1.03

±

+
±

1); Values are given as mean ± SE (n=6)
(sample " Cr release) - (spontaneous " Cr release)
2) ; % release = --------------------------------------------------------------------------- X 100
(maximal " Cr release) - (spontaneous " Cr release)
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Fig. IV-11 .
Effect of adrenalectomy on IL-2 production by non-stimulated (a) or
ConA-stimulated (b) T-lymphocytes of C57BU6 following lour-week AFB, exposure
measured by 3 H-TdR uptakes of HT-2 (IL-2 dependent) cells. Values are given as
mean ± SE (n=6). Asterisks indicate a significant difference produced by AFB,
treatment when compared to its respective control group (p<0.05) . N.C. = Nonoperated animal Control group, N.H . = Non-operated animal group treated with High
dose AFB,, S.C = Sham-operated animal Control group, S.H. = Sham-operated
animal group treated with High dose AFB,. A.C. = Adrenalectomized animal Control
group, A.H. =Adrenalectomized animal group treated with High dose AFB,. There
was a significant increase in A.C. when compared with N.C. in (a) (p<0.05) and a
significant decrease in A.C. when compared with N.C. in (b) (p<0.05).
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or sham-operated animals after ConA stimulation.

However, the background

production of IL-2 was not altered either by surgical procedures or treatment with
AFB, statistically.
Antibody production
Hemolytic plaque counting: The results sh own in Fig. IV-12a. indicate a reduction
of pl aque-forming cell (PFC) numbers per one million splenic cells in AFB,-treated
groups (p<0 .0 1). The same tendency was observed in the PFC number per spleen
(Fig . IV-12b.}.

Untreated, adrenalectomized animals sh owed significantly less

number of PFC, compared to non-treated controls.
ELISA: The optical density at 490-nm wave length in ELISA is shown in Fig . IV13. The treatment of mice with AFB, decreased the antibody level obtained by
ELISA in non-operated animals.

The level of specific anti-SRBC antibody was

decreased in sham-operated and adrenalectomized animals as well ; however, the
difference was not statistically significant.

Adrenalectomy caused a decrease in

antibody level when the groups not treated with AFB, were compared.
Endocrine Hormones
Corticotropin

releasing

factor

(CRF):

The

concentrations of CRF in the

hypothalamus and cerebral cortex are illustrated in Fig . IV-14a. and -14b.,
respectively.

As observed earlier in Set I experiments, the CRF level in the

hypothalamus was unaltered by the AFB, treatment. Similar effects were observed
after the AFB, treatment. Similar effects were also observed in the CRF levels in
the cerebral cortex of non-operated and sham-operated animals. The cerebral CRF
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Fig. IV-12.
Effect of adrenalectomy on the primary anti-SRBC
antibody-producing cell number in spleens of C57BU6 mice following
four-week AFB, exposure measured by PFC assay. (PFC/10' cells :
a, PFC/whole spleen: b) . Values are given as mean ± SE (n=6). For
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indicate the significant difference produced by AFB, treatment when
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compared with N.C. in (b) (p<O.OS).
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Effect of adrenalectomy on the concentration of CRF in
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in Fig. IV-11. Asterisk indicates a significant difference produced by
AFB, treatment when compared to its respective control group
(p<0.05). There was a significant decrease in AH. when compared
with N.C. and N.H. (p<0.01) and with S.C. and S.H. (p<0.05) in (b) .
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was reduced by the AFB, treatment in adrenalectomized animals (p<0.05).
Adrenocorticotropic hormone (ACTH) : In all groups, the AFB, treatment produced
a slight, albeit non-significant, increase in ACTH levels. The finding was similar
to that observed in Set I experiments where AFB, treatment also caused a slight,
non-significant increase in all treatment levels.

ACTH levels in the untreated ,

adrenalectomized group were increased compared to the non-operated or shamoperated control group. (Fig. IV-15.)
Corticosterone: Fig . IV-16. shows that AFB, treatment caused no change in any of
the three paired experiments.

The levels of corticosterone in the plasma of

adrenalectomized animals, however, were lower than non-operated and sham operated groups.
Brain amines
The concentrations of brain biogenic amines (NE, DA, and 5-HT) and their
major metabolites (DOPAC, HVA, and 5-HIAA) in the hypothalamus are illustrated
in Fig. IV-17. The effect of AFB, treatment was seen only in the decrease in the
concentration of DA and 5-HT in adrenalectomized animals. The concentration of
brain amines was also unaltered by sham-operation or adrenalectomy.
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Fig. IV-15.
Effect of adrenalectomy on the concentration of ACTH
in plasma of C57BU6 mice following four-week AFB, exposure
measured by RIA. Values are given as mean ± SE (n=6). For
identification of each group, refer to legends in Fig . JV-11 . Asterisk
indicates a significant difference produced by AFB, treatment when
compared to its respective control group (p<O.OS). There was a
significant increase in A.C. when compared with N.C. and S.C.
(p<0.01) and with N.H. (p<O.OS). There was a significant increase in
A.H. when compared with N.C., S.C., N.H., and S.H . (p<0.01) .
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Fig. IV-16.
Effect of adrenalectomy on the concentration of
corticosterone in plasma of C57BU6 mice following four-week AFB,
exposure measured by RIA. Values are given as mean ± SE (n=6) .
For identification of each group, refer to legends in Fig. IV-11 . There
was a significant decrease in A.C. and A.H. when compared with
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Effect of adrenalectomy on the concentration of the
various monoamine and their metabolites in the hypothalamus of
C57BU6 mice following four-week AFB 1 exposure measured by HPLC.
Values are given as mean ± SE (n=6}. For identification of each
group, refer to legends in Fig . IV-11 . Asterisks indicate a significant
difference produced by AFB, treatment when compared to its
respective control group {p<0.01 }.
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CHAPTER V
DISCUSSION
Aflatoxin B, has a unique position as a toxic chemical, since an enormous
amount of literature exists to describe its mechanism of toxicity, distribution in the
environment, and susceptibility difference in various animals. The extreme potency
in AFB, toxicity and its wide distribution make study important to protecting human
and animal health and associated economic consequences.
In this study, attention was focused on evaluation of the immunosuppressive
effects of AFB, in relation to the HPA axis and the involvement of this factor in
the mechanism of immunosuppression.
General effects of AFB, exposure
Aflatoxin B, exposure in C57BU6 mice daily over a period of four weeks did
not cause any severe effects on feed and water consumption, body weight gain,
and weights of liver, kidney, thymus, and spleen. Those parameters are generally
believed to be an indicator of toxicity following a chemical exposure.

In most

instances, the AFB, exposure was relatively mild, via consumption of food
contaminated by fungus (Aspergillus flavus or A. parasiticus) or contaminated,
airborne dust exposure. Except in a severe situation like famine, subjects can avoid
eating such heavily contaminated foods and thus becoming intoxicated with AFB,.
In the study of AFB, toxicology, the "mild" exposure, which does not cause acute
toxicity, is important to evaluating the real-life potential of AFB, toxicity.
The effects of AFB, on immune system
Aflatoxin B, exposure affected several parameters of the immune system in
this study, including proliferative response to several mitogens, i.e., specific to
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helper and suppressor T cell mitogen (ConA), B-cell mitogen (LPS), non-specific
mitogen (PWM), and IL-2 and antibody production.

However, there were no

significant differences shown in MLC, NK cell activity, and response to helper T cell
mitogen (PHA). The weights of thymus and spleen were not affected either. These
results indicate that the exposure to AFB, effects their proliferation and subsequent
antibody-producing activity.

The results showed more effects on systems that

require rapid protein synthesis.
Decreased proliferative response to ConA, which is both helper and
suppressor T cell mitogen , and lack of effect of PHA (a helper T cell mitogen) and
allogenic lymphocytes (also a helper T cell function) indicated a greater effect of
AFB, on suppressor T cells than other cell types.

However, the population of

suppressor T cells was not altered as indicated by flow cytometry. Changes in cell
population may occur over a longer period.

However, the results of mitogen-

induced cell proliferation indicate the AFB, treatment prevented the rapid
proliferation of splenocytes, particularly suppressor T cells.

Decrease in ConA-

induced IL-2 production by AFB, treatment also supported the above findings.
The effects of AFB, exposure on the immune system have been reported
earlier by several investigators. Aflatoxin B, had an immunosuppressive effect on
different species of animals and decreased their resistance to infectious disease.
Hoerr and D'Andrea (1983) described its effects on the lymphocyte response to
mitogens, inhibition of macrophage migration, delayed hypersensitivity skin response ,
and antibody titer to sheep erythrocytes in pigs. Giambrone et al. (1985a, 1985b,
1985c) reported its effects on cell-mediated immunity in chickens and turkeys. Pier
(1981) described the same effects in guinea pigs. Giambrone et al. (1985a, 1985b,
1985c) also found no effects on humoral immunity or on development of acquired
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immunity to Newcastle disease or fowl cholera vaccination in turkeys and chickens.
These findings are different from the present study since, in the present study using
mice, humoral immunity or acquired immunity were affected by AFB, treatment.
In another study using mice, Reddy et al. (1987) reported the reduction of
responses to several mitogens and mixed

lymphocy1e cultures (response to

allogeneic lymphocy1es), antibody production to SRBC (T-dependent antigen), and
in delayed-type hypersensitivity to keyhole limpet hemocyanin ; however, the antibody
production against T-independent antigen, LPS, was not affected. Galikeev et al.
(1968) showed a marked depression in antibody formation in mice before and
during the vaccination .
In the study by Reddy et al. (1987), they treated CD-1 mice with AFB, every
other day for two weeks (a cumulative dose up to 4.9 mglkg). Reddy and Sharma
(1989) used a cumulative dose of 9.8 mglkg in their study with BALB/c mice. In
the present study, a total dose of 21 mg/kg in daily dosing was required in
C57BU6 mice to produce immune effects. The mice used in this study appeared
to be relatively resistant to immunotoxic effects of AFB,.

The effects of AFB, on brain amine
Significant increases of NE and DA concentration in the hypothalamus were
observed in the AFB, study using CD-1 mice (Jayasekara et al., 1989).

The

decrease of NE concentration in the hypothalamus in Sprague-Dawley rats was
reported but not statistically significant (Coulombe and Sharma, 1985), whereas a
significant decrease of dopamine in the corpus striatum was also reported. In the
present study, AFB, effects appear similar to the rat study, with up to 21 mg/kg of
cumulative dose in daily treatment was applied to C57BU6 mice. Jayasekara et al.
(1989) used a cumulative dose of 3.9 mglkg (twice weekly four three weeks) on
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CD-1 mice. In the rat experiment, up to 2 mglkg cumulative (twice weeklyfor three
weeks) was used to evaluate AFB, neurotoxicity. The considerable difference in the
amount of cumulative AFB, exposure and its results suggest that C57BU6 mice are
highly resistant to AFB, neurotoxicity. The strain resistance will be discussed later.
The effects of AFB, on endocrine hormones

Corticotropin releasing factor (CRF) concentration in the hypothalamus
reported in the present study shows a value similar to that of the rat hypothalamus
(Fischman and Moldow, 1982). The method applied here was radioimmunoassay
(RIA) , designed for human and rat CRF. The validity of the method was checked
using rat cortex and hypothalamus (0.22 ± 0.01 ng/g wet tissue, 10.1 ± 1.3 ng/g wet
tissue, respectively), where values comparable to those reported in the literature
were observed.

Since the CRF of human and rat is identical, the CRF

measurement can be applied in both species. No information is available to apply
this RIA kit for the mice CRF measurement; however, results indicate that the
immunoassay can be successfully employed for mice. This suggests that the CRF
molecule of rat, mouse, and human have antigenically similar structures.
The concentration of CRF in the hypothalamus showed no significant
differences between control and treated groups. The concentration of CRF in the
cerebral cortex showed a statistically significant increase in the two highest dose
of AFB, in non-operated animals (p<0 .05), but in the case of AFB,-exposed
adrenalectomized animals, the cerebral CRF was significantly reduced (p<0.05).
The significance of this finding is not clear at present.
The concentration of CRF in the hypothalamus is ca. twenty times higher
than that in the cerebral cortex. The hypothalamic CRF role in homeostasis is
physiologically more important. The concentration is not the indication of secretion;
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in fact, ACTH concentration in the plasma of AFB,-treated animals was marginally
elevated.

But the elevation of ACTH did not correlate with the plasma

corticosterone elevation, the final products of HPA axis for a stress response .
The effect of adrenalectomy was apparent in elevated ACTH and decreased
corticosterone concentration in plasma.

The absence of an adrenal gland would

lead to less corticosterone, no feedback, and high concentration of stimulating
hormone (ACTH), which are all very reasonable effects of adrenalectomy. The
existence of corticosterone in plasma (even in low concentration) is not likely from
the remaider of any previous secretion before the adrenalectomy.

Taylor (1988,

p. 82) explained a similar result in his study in the following way: "Satellite adrenal
tissue, partial adrenal regeneration , or cross reactivity of the antibody used in the
RIA corticosterone detection system may account for detection of the hormone in
adrenalectomized animals." The specificity of the antiserum used in the present
study was checked for cross reactivity using various kinds of steroids, but the
association of cross reactivity was reported as negligible.
Evidently, the adverse effect of AFB, on the immune system is not likely to
be affected via the HPA axis.

Taylor (1988) and Taylor et a/. (1989) showed in

their studies the HPA axis involvement in T-2 toxin immunotoxicity. Hsieh (1988)
also concluded at least partial involvement in the adverse immunosuppressive effect
of benzene and toluene. In the case of T-2 toxin, the immunomodulation effects
were suggested to be the results of endotoxemia resulting from the damage of
gastric mucosa by T-2 toxin. Endotoxin is known to increase glucocorticohormones
(Agarwal and Lazar, 1977).
Strain susceptibility

From the results shown here, C57BU6 mice are relatively resistant to the
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effects of AFB,. Variation in the strain susceptibility to AFB, in various mice strains
was reported earlier. For the carcinogenic effect of AFB, in male White Swiss mice,
it was reported that 15 percent of the animals developed liver tumors with 1-ppm
dietary mycotoxin level (Newberne and Butler,

1969), whereas the same

concentration of AFB, in Swiss, C3HIB/Hen, and C57BUSNB did not show any
tumors even after 70 weeks of treatment (Wogan, 1969). The mouse in general is
a relatively resistant species for the toxic effects of AFB,.
The mechanism of difference in toxicity between species or strains cannot
be explained from observations in the present study. As mentioned earlier, in CD1 mice exposed to AFB, every other day for two weeks (cumulative dose up to 4.9
mglkg) showed considerable immunosuppression (Reddy et al., 1987). In another
study, a cumulative dose of 9.8 mg/kg showed AFB, effects on the immune system
in BALB/c mice (Reddy and Sharma, 1989). In the present study, a dose of up to
21 mg AFB,Ikg with daily dosing was applied to C578U6 mice with similar effects.
To investigate neurotoxicology, Jayasekara et al. (1989) used up to 3.9
mglkg (twice weekly for 3 weeks) on CD-1 mice and found changes in brain amine
concentration. However, no significant changes were observed in the present study,
even at the higher dosage.
From the toxicokinetical point of view, their dosing method--every other day
or twice weekly--is considerably mild compared to daily dosing.

With this mild

exposure, the detoxication mechanism should work more effectively due to better
conjugation and excretion (less load). Despite this, the effects of AFB, exposure
in C57BU6 mice were considerably less than that of CD-1 animals.
The differences in the toxic effects of AFB, in different strains can be
explained on the basis of differences in metabolic transformation of the chemical.
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Monroe and Eaton (1987, 1988) focused on the species difference between mouse
and rat to the AFB,-induced hepatocarcinogenicity and explained that differences
in glutathione S-transferase (GST) activity toward AFB,-epoxide is probably the
cause. Mouse liver cy1osol had 52 times greater GST activity, compared to that of
the rat. They concluded that GST activity is the principal determinant of species
difference in susceptibility to AFB,-induced hepatocarcinogenicity. The differences
seen between strains C57BU6 and CD-1

or BALB/c in immunotoxicity or

neurotoxicity of AFB, need further investigation to explain this mechanism.
The effects of adrenalectomy

The experiments using adrenalectomized animals showed some different
responses compared to non-operated or sham-operated animals.

As mentioned

earlier, the concentration of ACTH increased drastically, and lower amounts ol
corticosterone were observed in adrenalectomized animals. Besides these effects,
IL-2 production was lower in adrenalectomized animals' splenic cells stimulated by
ConA, compared with those of non-operated or sham-operated animals' cells. They
showed reduced response for specific antibody production when challenged to
SRBC.

Both

the

plaque-forming

cell

(PFC)

assay

and

enzyme-linked

immunosorbent assay (ELISA) showed similar results ; a similar tendency was
observed by Taylor (1988) . The corticotropin releasing factor (CRF) in the cerebral
cortex of adrenalectomized animals was decreased after the AFB, treatment.

In

most cases, AFB,-exposed adrenalectomized animals showed a larger alteration of
the immune parameter, compared with the other groups, but changes were
marginal. The AFB,-treated adrenalectomized animals endured a dual burden, one
from the surgical removal of adrenal glands and secondly, the AFB, challenge.
The mechanism of such effects was beyond the scope of the present study;
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however, alterations in hormone levels and CRF are consistent with the effects
expected from interruption of HPA cycle.
General

These studies apparently indicate that the HPA axis does not play any
significant role in AFB,-induced immune suppression in C578U6 mice. In spite of
the fact that this strain is highly resistent to the immunologic effects of AFB,. the
dose used here produced sufficient immunotoxicity with no alteration of brain
amines, CRF, or circulating hormones. Whether this observation can be generalized
to other strains or species need to be evaluated in the future .
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CHAPTER VI
CONCLUSIONS
Aflatoxin B,. a secondary metabolite of Aspergillus flavus and Aspergillus
parasiticus, was given orally to C57BU6 black mice daily for four weeks and

evaluated as to its immunotoxicity, neurotoxicity, and the effects on the endocrine
hormone. Two sets of the same type of experiments were designed to evaluate
HPA-axis involvement in AFB, immunotoxicity. A relatively higher dose was applied
in the present study as compared to previous studies, using a different strain of
mice.
Immunosuppressive effects were observed in mitogenic response , IL-2
production, and primary antibody production of splenic cells. The circulating anti SRBC antibody was also decreased. Decrease was observed in helper T and B
cell ratio in phenotyping of splenic lymphocyte.

No significant changes were

observed in cytolytic cell activity, mixed lymphocyte response, brain amine, or
hormone.

The

expected

effect

of

adrenalectomy

to

compensate

for

immunosuppression of AFB, was not observed ; in fact, suppression was actually
increased in some cases.
Results indicate that the HPA axis is not involved in AFB, immunotoxicity.
Secondly, the strain of mouse used in the present study, C57BU6, is more resistant
to the effects of AFB, compared to other strains studied (C0-1, outbred white
mouse; BALB/c, inbred white mouse) .
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